Over the course of three decades in private practice, Rob has been a key player in advising companies involved in industry-defining transactions.
Much has changed over the past 30 years in the healthcare and life sciences industries and in allied fields such as medical devices, information technology, biopharmaceuticals, software, and commercial and regulatory services. Rob has advised and represented clients on transactions, with many of those helping to shape the direction of the industry. He has counseled clients contemplating mergers, acquisitions, divestitures, joint ventures, strategic alliances and other commercial transactions across multiple industry segments, including healthcare payer service providers, digital health, home healthcare, software and AI, and technology and service providers to the healthcare industry, in addition to companies that develop medical devices and biopharma therapies and technologies.
In addition to his strategic transaction experience, Rob routinely represents clients on a wide variety of capital markets transactions, including public and private debt and equity offerings, as well as associated securities and regulation compliance and corporate governance concerns.
Beyond healthcare and allied industries, Rob also represents clients on transactions and other financing matters in a variety of business sectors, including industrial and manufacturing, real estate development, technology and e-commerce, consumer products and services, and financial services.
Robert serves as the Office Managing Partner for Husch Blackwell's Minneapolis office.